Hydrogen-bonding compounds, compositions comprising the same, and methods of preparing and using the same

US11286231B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11286231-B2
Application numberUS-201716344452-A
CountryUS
Kind codeB2
Filing dateOct 26, 2017
Priority dateOct 26, 2016
Publication dateMar 29, 2022
Grant dateMar 29, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are compounds having a hydrogen-bonding group and optionally a functional group for binding (e.g., covalently binding) the compound to another compound (e.g., hyaluronic acid and/or gelatin). A compound of the present invention may have a structure represented by and/or comprising Formula I, Formula II, Formula III, Formula IV, Formula IV′, Formula V, Formula V′, Formula VI, Formula VII, and/or Formula VIII as described herein. Compositions including compounds of the present invention along with methods of preparing and using the same are also described herein.

First claim

Opening claim text (preview).

That which is claimed is: 1. A modified polysaccharide comprising at least one polysaccharide unit including a moiety having a structure represented by Formula IV or Formula V: wherein A and B are each independently selected from the group consisting of hydrogen, —OH, chlorine, fluorine, —CO 2 H, —CO 2 CH 3 , —NH 2 , and —NHCOCH 3 ; Z is —NR 3 (CH 2 ) p —, —O(CH 2 ) p —, —NR 3 (CH 2 ) p O—, —NR 3 (CH 2 ) p NR 3 —; R 2 is hydrogen or ═O; R 3 is hydrogen or is absent; R 4 is hydrogen or C 1 -C 4 alkyl; and p is an integer from 0 to 11. 2. The modified polysaccharide of claim 1 , wherein the modified polysaccharide is hyaluronic acid. 3. The modified polysaccharide of claim 1 , wherein the moiety is bound to the at least one polysaccharide unit via a thiol linkage to provide a structure represented by Formula IV′ or Formula V′: wherein A and B are each independently selected from the group consisting of hydrogen, —OH, chlorine, fluorine, —CO 2 H, —CO 2 CH 3 , —NH 2 , and —NHCOCH 3 ; Z is —NR 3 (CH 2 ) p —, —O(CH 2 ) p —, —NR 3 (CH 2 ) p O—, —NR 3 (CH 2 ) p NR 3 —; R 2 is hydrogen or ═O; R 3 is hydrogen or is absent; R 4 is hydrogen or C 1 -C 4 alkyl; and p is an integer from 0 to 11. 4. The modified polysaccharide of claim 1 , wherein the moiety has a structure selected from the group consisting of: wherein A and B are each independently selected from the group consisting of hydrogen, —OH, chlorine, fluorine, —CO 2 H, —CO 2 CH 3 , —NH 2 , and —NHCOCH 3 . 5. The modified polysaccharide of claim 1 , wherein the moiety has a structure selected from the group consisting of: wherein A and B are each independently selected from the group consisting of hydrogen, —OH, chlorine, fluorine, —CO 2 H, —CO 2 CH 3 , —NH 2 , and —NHCOCH 3 ; and R 4 is hydrogen or C 1 -C 4 alkyl. 6. The modified polysaccharide of claim 5 , wherein R 4 is methyl. 7. The modified polysaccharide of claim 5 , wherein R 4 is hydrogen. 8. A modified gelatin comprising at least one moiety bound to the gelatin backbone via a thiol linkage to provide a structure represented by Formula IV′ or Formula V′: wherein A and B are each independently selected from the group consisting of hydrogen, —OH, chlorine, fluorine, —CO 2 H, —CO 2 CH 3 , —NH 2 , and —NHCOCH 3 ; Z is —NR 3 (CH 2 ) p —, —O(CH 2 ) p —, —NR 3 (CH 2 ) p O—, —NR 3 (CH 2 ) p NR 3 —; R 2 is hydrogen or ═O; R 3 is hydrogen or is absent; R 4 is hydrogen or C 1 -C 4 alkyl; and p is an integer from 0 to 11.

Assignees

Inventors

Classifications

  • having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings · CPC title

  • Gelatin · CPC title

  • C07C235/46Primary

    having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms · CPC title

  • C07C215/50Primary

    with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11286231B2 cover?
Described herein are compounds having a hydrogen-bonding group and optionally a functional group for binding (e.g., covalently binding) the compound to another compound (e.g., hyaluronic acid and/or gelatin). A compound of the present invention may have a structure represented by and/or comprising Formula I, Formula II, Formula III, Formula IV, Formula IV′, Formula V, Formula V′, Formula VI, Fo…
Who is the assignee on this patent?
Univ Wake Forest Health Sciences, Univ Wake Forest
What technology area does this patent fall under?
Primary CPC classification C07C235/46. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).